Inhibition of Bradykinin in COVID-19 Infection With Icatibant

NCT05407597 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

SARS CoV 2 Infection

Interventions

DRUG: Icatibant
DRUG: 0.9% Sodium Chloride Injection

Sponsor

Belfast Health and Social Care Trust

Collaborators

[object Object]